Back
Oruka Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
ORKA
Oruka Therapeutics, Inc.
Last Price:
$33.71
Seasonality Move:
-7.41%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight selling pressure.
Oruka Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.93 | Buy |
| 20-day SMA: | 30.33 | Buy |
| 50-day SMA: | 29.55 | Buy |
| 200-day SMA: | 18.49 | Buy |
| 8-day EMA: | 31.6 | Buy |
| 20-day EMA: | 30.53 | Buy |
| 50-day EMA: | 28.95 | Buy |
| 200-day EMA: | 22.49 | Buy |
Oruka Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.79 | Buy |
| Relative Strength Index (14 RSI): | 62.18 | Buy |
| Chaikin Money Flow: | -78330 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.13 - 32.21) | Buy |
| Bollinger Bands (100): | (19.11 - 31.07) | Buy |
Oruka Therapeutics, Inc. Technical Analysis
| Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Oruka Therapeutics, Inc. Stock
Is Oruka Therapeutics, Inc. Stock a Buy?
-
Oruka Therapeutics, Inc. share price is 33.23 while ORKA 8-day simple moving average is 30.93, which is a Buy signal.
-
The stock price of ORKA is 33.23 while Oruka Therapeutics, Inc. 20-day SMA is 30.33, which makes it a Buy.
-
Oruka Therapeutics, Inc. 50-day simple moving average is 29.55 while ORKA share price is 33.23, making it a Buy technically.
-
ORKA stock price is 33.23 and Oruka Therapeutics, Inc. 200-day simple moving average is 18.49, creating a Buy signal.
ORKA Technical Analysis vs Fundamental Analysis
Sell
49
Oruka Therapeutics, Inc. (ORKA)
is a Sell
Is Oruka Therapeutics, Inc. a Buy or a Sell?
-
Oruka Therapeutics, Inc. stock is rated a SellThe current Oruka Therapeutics, Inc. [ORKA] share price is $33.23. The Score for ORKA is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Oruka Therapeutics, Inc. Stock Info
Market Cap:
1.6B
Price in USD:
33.23
Share Volume:
451.5K
Oruka Therapeutics, Inc. 52-Week Range
52-Week High:
34.38
52-Week Low:
5.49
Sell
49
Oruka Therapeutics, Inc. (ORKA)
is a Sell
Oruka Therapeutics, Inc. Share Price Forecast
-
What is the Oruka Therapeutics, Inc. stock price today?The Oruka Therapeutics, Inc. stock price is 33.23 USD today.
-
Will ORKA stock go up or go down?Oruka Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Oruka Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Oruka Therapeutics, Inc. is overvalued.
Is Oruka Therapeutics, Inc. Stock a Buy?
-
Oruka Therapeutics, Inc. share price is 33.23 while ORKA 8-day exponential moving average is 31.60, which is a Buy signal.
-
The stock price of ORKA is 33.23 while Oruka Therapeutics, Inc. 20-day EMA is 30.53, which makes it a Buy.
-
Oruka Therapeutics, Inc. 50-day exponential moving average is 28.95 while ORKA share price is 33.23, making it a Buy technically.
-
ORKA stock price is 33.23 and Oruka Therapeutics, Inc. 200-day simple moving average is 22.49, creating a Buy signal.
Fundamental Analysis of Oruka Therapeutics, Inc.
Is Oruka Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.31 per share.
Technical Analysis of Oruka Therapeutics, Inc.
Should I short Oruka Therapeutics, Inc. stock?
-
ORKA Moving Average Covergence Divergence (MACD) indicator is 0.79, suggesting Oruka Therapeutics, Inc. is a Buy
-
Oruka Therapeutics, Inc. Relative Strength Index (RSI) is 62.18, which suggest Oruka Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Oruka Therapeutics, Inc. is (28.13 - 32.21), which suggest Oruka Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Oruka Therapeutics, Inc. is (19.11 - 31.07), which suggest Oruka Therapeutics, Inc. is a Buy
* Oruka Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.